Attached files
| file | filename |
|---|---|
| 10-K - ANNUAL REPORT - Cellular Biomedicine Group, Inc. | ebig_10k.htm |
| EX-31.2 - CERTIFICATION - Cellular Biomedicine Group, Inc. | ebig_ex312.htm |
| EX-31.1 - CERTIFICATION - Cellular Biomedicine Group, Inc. | ebig_ex311.htm |
| EX-21.1 - EXHIBIT 21.1 - Cellular Biomedicine Group, Inc. | ebig_ex211.htm |
| EX-10.10 - EXHIBIT 10.10 - Cellular Biomedicine Group, Inc. | ebig_ex1010.htm |
| EX-10.11 - EXHIBIT 10.11 - Cellular Biomedicine Group, Inc. | ebig_ex1011.htm |
| EX-10.19 - EXHIBIT 10.19 - Cellular Biomedicine Group, Inc. | ebig_ex1019.htm |
| EX-10.16 - EXHIBIT 10.16 - Cellular Biomedicine Group, Inc. | ebig_ex1016.htm |
| EX-10.15 - EXHIBIT 10.15 - Cellular Biomedicine Group, Inc. | ebig_ex1015.htm |
| EX-10.18 - EXHIBIT 10.18 - Cellular Biomedicine Group, Inc. | ebig_ex1018.htm |
| EX-10.14 - EXHIBIT 10.14 - Cellular Biomedicine Group, Inc. | ebig_ex1014.htm |
| EX-10.17 - EXHIBIT 10.17 - Cellular Biomedicine Group, Inc. | ebig_ex1017.htm |
| EX-10.20 - EXHIBIT 10.20 - Cellular Biomedicine Group, Inc. | ebig_ex1020.htm |
EXHIBIT 32
Section 1350 Certifications
Pursuant to 18 U.S.C. § 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned officers of EastBridge Investment Group Corporation, an Arizona corporation (the Company), hereby certify that:
To my knowledge, the Annual Report on Form 10-K of the Company for the annual period ended December 31, 2009 (the Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Dated: April 13, 2010
|
||||
|
|
/s/ Keith Wong
|
|||
|
|
Keith Wong
|
|||
|
|
Chief Executive Officer
|
|||
| Dated: April 13, 2010 | ||||
|
/s/ Norm Klein
|
||||
| Norm Klein | ||||
|
Principal Financial Officer
|